Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker

Figure 7

Pan-cancer correlation between CDK1 and 44 RNA methylation regulatory proteins. RNA methylation modifications are divided into three categories: m1A, m5A, and m6C; modified protein types are divided into three categories: writer, reader, and eraser.